SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-011597 to SBC Medical Group Holdings Inc (SBC, SBCWW) (CIK 0001930313) (SBC)

SBC Medical Group Holdings Inc (SBC, SBCWW) (CIK 0001930313)
Date: Oct. 15, 2024 · CIK: 0001930313 · Accession: 0000000000-24-011597

Regulatory Compliance Financial Reporting Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-282540

Date
October 15, 2024
Author
Yoshiyuki Aikawa
Form
UPLOAD
Company
SBC Medical Group Holdings Inc (SBC, SBCWW) (CIK 0001930313)

Letter

October 15, 2024 Yoshiyuki Aikawa Chief Executive Officer SBC Medical Group Holdings Inc. 200 Spectrum Center Dr., Suite 300 Irvine, CA 92618 Re:SBC Medical Group Holdings Inc. Registration Statement on Form S-1 Filed October 8, 2024 File No. 333-282540 Dear Yoshiyuki Aikawa: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Craig D. Linder, Esq.

Show Raw Text
October 15, 2024
Yoshiyuki Aikawa
Chief Executive Officer
SBC Medical Group Holdings Inc.
200 Spectrum Center Dr., Suite 300
Irvine, CA 92618
Re:SBC Medical Group Holdings Inc.
Registration Statement on Form S-1
Filed October 8, 2024
File No. 333-282540
Dear Yoshiyuki Aikawa:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Craig D. Linder, Esq.